NasdaqGS - Delayed Quote USD
Caribou Biosciences, Inc. (CRBU)
1.1300
+0.0800
+(7.62%)
At close: June 4 at 4:00:01 PM EDT
1.1199
-0.01
(-0.89%)
After hours: June 4 at 7:34:10 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-137,722
-138,200
-93,291
-90,966
-32,519
Investing Cash Flow
113,032
86,607
-68,183
-93,249
-176,397
Financing Cash Flow
4,707
16,724
154,298
2,133
433,429
End Cash Position
29,463
16,339
51,208
58,384
240,466
Income Tax Paid Supplemental Data
--
0
170
0
11
Capital Expenditure
-4,599
-6,505
-11,613
-7,054
-3,121
Issuance of Capital Stock
3,863
15,192
152,720
0
429,847
Issuance of Debt
--
--
--
0
1,150
Repayment of Debt
--
--
--
0
-119
Free Cash Flow
-142,321
-144,705
-104,904
-98,020
-35,640
12/31/2021 - 7/23/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VERV Verve Therapeutics, Inc.
5.29
+9.07%
PRME Prime Medicine, Inc.
1.3200
-0.75%
BEAM Beam Therapeutics Inc.
17.15
+1.60%
EDIT Editas Medicine, Inc.
1.8200
0.00%
FATE Fate Therapeutics, Inc.
1.4200
+4.41%
NTLA Intellia Therapeutics, Inc.
7.67
-0.26%
ALLO Allogene Therapeutics, Inc.
1.2900
-4.44%
BDTX Black Diamond Therapeutics, Inc.
2.5400
+1.60%
SANA Sana Biotechnology, Inc.
2.3200
-0.85%
PBYI Puma Biotechnology, Inc.
3.5600
+7.39%